September 2, 2025

Meren Energy Appoints Oliver Quinn as Chief Commercial & Operating Officer

Meren Energy Inc. (MER:TO) has announced that Craig Knight, Chief Operating Officer (COO), has stepped down from his role effective August 31, 2025, to return to Australia for personal reasons...

Fidelity Emerging Markets shareholders to benefit on repurchase of Strathclyde’s holding

Fidelity Emerging Markets Limited has agreed a conditional share repurchase deal with Strathclyde Pension Fund for its entire 25.7% holding, subject to shareholder approval. The £NAV-discounted repurchase is expected to..

Harrow, Inc. (HROW) Stock Analysis: Evaluating Robust Growth with 54.10% Upside Potential

Harrow, Inc. (NASDAQ: HROW) is capturing the attention of investors in the healthcare sector, particularly within the niche of ophthalmic pharmaceuticals. With a market capitalization of $1.44 billion, Harrow, Inc...

Integra LifeSciences Holdings C (IART) Stock Analysis: Insights Into Its 4.92% Potential Upside

Integra LifeSciences Holdings C (IART) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. The company, headquartered in Princeton, New Jersey, has carved a niche..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 138% Potential Upside in Biotechnology

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is drawing significant attention in the biotechnology sector, not only for its innovative approach to tackling diseases driven by dysregulated aldosterone but also for its..

Mesoblast Limited (MESO) Stock Analysis: Unveiling a 95% Potential Upside in the Biotech Sector

Mesoblast Limited (NASDAQ: MESO) is capturing the attention of investors with its promising regenerative medicine platform and a significant potential upside of 95.23%. Specializing in groundbreaking treatments for severe inflammatory..

Aurinia Pharmaceuticals (AUPH) Stock Analysis: Navigating a 22.4% Revenue Growth Amidst a Competitive Biotech Landscape

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a key player in the biotechnology sector, continues to capture investor attention with its promising growth trajectory and innovative therapeutic solutions. Headquartered in Edmonton, Canada,..

The Pennant Group, Inc. (PNTG) Stock Analysis: Unpacking a 39.94% Potential Upside

Investors with an eye on the healthcare sector might find The Pennant Group, Inc. (NASDAQ: PNTG) an intriguing prospect. Headquartered in Eagle, Idaho, Pennant operates within the Medical Care Facilities..

10x Genomics, Inc. (TXG) Stock Analysis: Assessing the 7.62% Potential Upside for Investors

10x Genomics, Inc. (NASDAQ: TXG) stands at the forefront of innovation within the healthcare sector, specifically in the health information services industry. Founded in 2012 and headquartered in Pleasanton, California,..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a Potential 37% Upside for Investors

Astrana Health Inc. (ASTH) is making waves in the healthcare sector with promising growth prospects and a solid market position. With a current market capitalization of $1.48 billion, this Alhambra,..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 41.57% Potential Upside in the Healthcare Sector

Pulse Biosciences, Inc. (NASDAQ: PLSE) is making waves in the healthcare sector with its innovative bioelectric medicine solutions. Operating primarily in the medical instruments and supplies industry, the company has..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Unpacking the 34% Potential Upside in the Medical Device Sector

Investors with an eye on the healthcare sector, particularly the medical device industry, may find Establishment Labs Holdings Inc (NASDAQ: ESTA) a compelling prospect. Headquartered in Alajuela, Costa Rica, this..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Through Healthcare with a 8.06% Potential Upside

Azenta, Inc. (NASDAQ: AZTA) offers a compelling story for investors in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $1.4 billion and..

NeoGenomics, Inc. (NEO) Stock Analysis: Decoding a 11.36% Potential Upside in the Diagnostics Sector

NeoGenomics, Inc. (NASDAQ: NEO), a key player in the diagnostics and research industry, presents a compelling opportunity for investors looking to tap into the healthcare sector. With a market capitalization..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Eyeing a 108.92% Potential Upside in Biotech

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a promising player in the biotechnology sector, offers investors an intriguing opportunity with a potential upside of 108.92%, according to analysts’ average target price. Specializing..

Adaptive Biotechnologies Corp (ADPT) Stock Analysis: Investor Outlook and Growth Potential in the Biotech Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) is capturing the attention of investors with its innovative approach to healthcare, particularly in the burgeoning field of biotechnology. With a market capitalization of $2.01..

Aveanna Healthcare Holdings Inc (AVAH) Investor Outlook: Navigating Growth in Home Care with a 16.8% Revenue Surge

Aveanna Healthcare Holdings Inc (AVAH), a prominent player in the healthcare sector, offers a compelling narrative for investors focused on the medical care facilities industry. Headquartered in Atlanta, Georgia, Aveanna..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: A Promising 26.4% Upside Potential in the Biotech Sector

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), with its headquarters in Cambridge, Massachusetts, is a notable player in the biotechnology segment of the healthcare sector. The company is primarily focused on the..

Phreesia, Inc. (PHR) Stock Analysis: Navigating 45.7% Revenue Growth in the Health Information Services Sector

Phreesia, Inc. (NYSE: PHR) stands as a notable player in the healthcare sector, particularly within the health information services industry. Known for its integrated SaaS-based software and payment platform, Phreesia..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Exploring a 278.64% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its innovative approach to developing oral small molecule therapeutics aimed at addressing chronic diseases..

Search

Funds

September 2, 2025

Fidelity Emerging Markets shareholders to benefit on repurchase of Strathclyde’s holding

Fidelity Emerging Markets Limited has agreed a conditional share repurchase deal with Strathclyde Pension Fund for its entire 25.7% holding, subject to shareholder approval. The £NAV-discounted repurchase is expected to complete in November 2025, cancelling 16.4m shares and delivering an estimated 4% uplift to NAV per share for ongoing shareholders...
Search

Funds

September 2, 2025

FTSE 100

Funds